Feasibility study of focused ultrasound in the treatment of vulvar low-grade squamous intraepithelial lesions with persistent symptoms

Chang Su Xinglin Liu Can Wu Xi Wang Chengzhi Li a State Key Laboratory of Ultrasound in Medicine and Engineering,College of Biomedical Engineering,Chongqing Medical University,Chongqing,Chinab Chongqing Key Laboratory of Biomedical Engineering,Chongqing Medical University,Chongqing,Chinac Department of Gynecology,Chongqing Haifu Hospital,Chongqing,China
DOI: https://doi.org/10.1080/02656736.2024.2365975
2024-06-13
International Journal of Hyperthermia
Abstract:Objective This study aimed to investigate the feasibility, efficacy, and safety of focused ultrasound (FUS) for the treatment of vulvar low-grade squamous intraepithelial lesions (VLSIL) with persistent symptoms.
oncology,radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the feasibility, effectiveness and safety of focused ultrasound (FUS) in the treatment of vulvar low - grade squamous intraepithelial lesion (VLSIL) with persistent symptoms. Specifically, the study aims to explore the following issues: 1. **Feasibility**: Whether focused ultrasound can be used as a feasible treatment method for VLSIL patients. 2. **Effectiveness**: Whether focused ultrasound can effectively relieve the clinical symptoms (such as itching) of patients and improve the histopathological manifestations. 3. **Safety**: Whether there are significant adverse reactions or complications during the focused ultrasound treatment process. ### Research Background Vulvar squamous intraepithelial lesion (VSIL) is an intraepithelial disease that occurs in the female external genitalia and is related to human papillomavirus (HPV) infection. According to the 2015 classification scheme of ISSVD (International Society for the Study of Vulvovaginal Disease), VSIL is re - classified into three types: - Vulvar low - grade squamous intraepithelial lesion (VLSIL) - Vulvar high - grade squamous intraepithelial lesion (VHSIL), which is related to HPV infection - Differentiated vulvar intraepithelial neoplasia (dVIN), which is not related to HPV infection VLSIL usually includes flat warts and temporary HPV infections. These lesions are not precancerous lesions and do not require treatment when asymptomatic. However, for VLSIL patients with persistent symptoms (such as long - term itching), the existing treatment methods (such as imiquimod ointment or laser treatment) may lead to complications such as ulceration and scar formation, and may reduce patient compliance. ### Research Purpose The main purpose of this study is to evaluate the feasibility, effectiveness and safety of focused ultrasound (FUS) in the treatment of VLSIL patients with persistent symptoms, and to provide new solutions for this non - invasive treatment method. ### Research Methods - **Patient Selection**: Retrospective analysis was performed on the data of 24 VLSIL patients who received FUS treatment. - **Treatment Method**: The Seapostar ultrasonic treatment device was used for treatment, and the parameter settings were power 3.5 - 4.0 W, frequency 10.4 MHz, and pulse frequency 1000 Hz. - **Follow - up Evaluation**: Follow - up was carried out at 1, 3 and 6 months after treatment to evaluate the clinical symptoms (such as the degree of itching) and histopathological changes of patients. ### Main Results - **Clinical Effect**: After treatment, the itching score of patients decreased from 2.55 ± 0.51 to 0.77 ± 0.81 (p < 0.05). The clinical response rate was 86.4%, of which the complete response rate was 54.5% and the partial response rate was 31.8%. - **Pathological Response**: The histopathological response rate was 81.8%, indicating that the lesion tissues of most patients returned to normal. - **Safety**: Only one patient had ulceration after treatment, but it healed after symptomatic anti - inflammatory treatment without leaving a scar. No other patients had serious adverse reactions. ### Conclusion The study shows that focused ultrasound is a feasible, effective and safe method for treating VLSIL with persistent symptoms, providing a new option for non - invasive treatment. In the future, multi - center randomized controlled trials with a larger sample size are needed to further verify these results.